API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TO /
  3. MDP.TO

Medexus Pharmaceuticals Inc (MDP TO) stock market data APIs

C$2.97 0.45(17.9%) as of October 18, 2024
Price chart is built with Anychart

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical revolutionary treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Toronto, Canada.

Medexus Pharmaceuticals Inc Financial Data Overview

2.39
2.97
-
2.69
2.15
1.44-3.16
64 511 K
43.3333
24 526 K
109 M
0.08
1.956
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MDP',
Type: 'Common Stock',
Name: 'Medexus Pharmaceuticals Inc',
Exchange: 'TO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA58410Q2036',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Medexus Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 109 M
  • EBITDA 17 858 K
  • Earnings Per Share 0.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Medexus Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-08-07
  • EPS/Forecast 0.04

Get Medexus Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Medexus Pharmaceuticals Inc latest news via APIs

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an agreem...
  • FINANCING AGREEMENTS
  • INC
  • MEDEXUS PHARMACEUTICALS
  • TORONTO STOCK EXCHANGE:MDP

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom Burton...
  • CALENDAR OF EVENTS
  • MEDEXUS PHARMACEUTICALS INC
  • TORONTO STOCK EXCHANGE:MDP
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com